🇺🇸

US SEC Filing Intelligence

· daily

Federal Professional Services Contracts — October 01, 2026

This digest covers a single, large-award contract from the General Services Administration (GSA) to Science Applications International Corporation (SAIC) valued at $526.5 million, with zero defense-related contracts in the period. The dominant theme is civilian-agency investment in Air Force training and simulation capabilities, executed through GSA’s FEDSIM vehicle. The highest-conviction signal is neutral: SAIC’s competitive win demonstrates strength in engineering services, but the cost-plus-award-fee structure, negative outlayed balance, and 90% subaward pass-through rate introduce execution and cash-flow risks. Key watch items include SAIC’s quarterly revenue recognition and any contract modifications before the December 2025 performance end.

1 total filings
· daily

All HHS Contracts — October 01, 2026

The two HHS contracts totaling $1.55 billion reveal a dominant civilian-sector theme of pandemic preparedness and healthcare administrative infrastructure, with no direct defense-related awards despite one contract being labeled 'defense-related' due to BARDA's dual-use mission. The highest-conviction signal is the $988.2 million sole-source award to PALMETTO GBA, LLC for Medicare administrative services, indicating a durable, high-margin revenue stream for a private contractor. However, the $563.7 million BARDA award to nonprofit ATI carries significant execution risk due to minimal outlays ($1.9M) and a fixed-price R&D structure. Key watch items include ATI's contract ramp-up and PALMETTO GBA's performance under potential Continuing Resolution uncertainty.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — October 01, 2026

The five contracts in this digest total $3.83 billion in obligations, with only one (SAIC's $526.5M AFAMS award) directly defense-related, underscoring a civilian-heavy federal procurement environment. The dominant theme is the Department of Education's direct loan servicing modernization, with Nelnet ($988.7M) and Maximus ($764.4M) winning large firm-fixed-price delivery orders under full-and-open competition, signaling a duopoly-like concentration in that niche. The highest-conviction signal is Nelnet's $1.64B in outlays against a $983.7M contract, indicating scope expansion and robust cash flow, though fixed-price execution risk looms. A key watch item is the December 31, 2024 contract end date for both Nelnet and Maximus, with re-compete announcements likely to drive sector sentiment. Risk is concentrated in the SAIC cost-plus-award-fee structure, where negative outlays and heavy subaward pass-through (90% of value) could compress margins, and in the early-stage BARDA vaccine contract (ATI) with minimal outlays to date.

5 total filings
· daily

High-Value Federal Grants ($5M+) — October 01, 2026

This digest covers $3.83 billion in total obligations across five high-value federal contracts, with only one of five being defense-related (SAIC's $526M AFAMS award), signaling a civilian-heavy period dominated by the Department of Education and HHS. The highest-conviction signal is the combined $1.75 billion in Education Department loan servicing awards to Nelnet Servicing LLC and MAXIMUS Education LLC, both of which have already outlayed significantly above their base values, indicating strong, durable revenue streams. However, the fixed-price structure on both contracts introduces margin execution risk, and both expire on December 31, 2024, creating a critical re-compete catalyst. A key risk is the minimal outlay on Advanced Technology International's $564M BARDA vaccine contract, suggesting early-stage funding that may not ramp as expected.

5 total filings
· daily

General Federal Contracts — October 01, 2026

This digest covers $3.83 billion in total obligations across 5 contracts, with only 1 of 5 being defense-related (SAIC’s $526M Air Force training award), signaling a heavy civilian tilt this period. The dominant theme is Department of Education loan servicing, where Nelnet Servicing LLC ($989M) and MAXIMUS Education LLC ($764M) collectively account for $1.75B, but both contracts expire December 31, 2024, creating near-term revenue cliff risk. The highest-conviction signal is the SAIC cost-plus-award-fee contract, which offers low execution risk but limited upside due to $477.5M in subaward pass-throughs. Key risk: the two Education Department contracts have already outlaid $2.74B combined—well above their base values—suggesting scope creep or cost overruns that may not recur. Watch for recompete announcements for both loan servicing contracts in Q4 2024.

5 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 01, 2026

The 27 filings in this S&P 500 Technology stream are dominated by routine insider transactions (director fee shares, RSU conversions, and small gifts) across IBM, Fortinet, Palantir, Apple, and Oracle, with only one material corporate event: Accenture's Q4 FY2026 earnings. Accenture's results show a mixed picture—revenue beat guidance (Q4 $18.68B, +6% USD, +7% local currency) and FY2026 adjusted EPS grew 8% to $13.97, but free cash flow declined sharply (Q4 $2.85B vs $3.81B YoY), DSOs rose to 50 days from 47, and FY2027 guidance of 3%-6% local-currency growth signals deceleration. Insider activity is largely neutral, except for Oracle director Stephen Rusckowski's $3.48M open-market purchase (bullish) and Apple SVP Jennifer Newstead's $806K sale under a 10b5-1 plan (mildly bearish). The sector theme is one of modest growth with margin and cash-flow pressures, as seen in Accenture's rising tax rate (25.1% vs 23.7%) and slowing regional growth (Asia Pacific +3% USD). No major capital allocation or M&A transactions were disclosed in this batch.

22 high priority 5 medium 27 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 01, 2026

The 7 filings reveal a mixed insider activity landscape across NASDAQ-100 constituents. Apple and CoreWeave both reported insider sales, with CoreWeave's CEO selling $7.7M across 11 transactions—a significant bearish signal for a high-growth AI infrastructure company. In contrast, Palantir awarded stock and SARs to three executives, indicating retention and alignment with long-term performance. Strategy Inc announced a 12% dividend on its preferred stock with a conditional switch to daily dividends pending shareholder approval on October 28, 2026, a key catalyst for income-focused investors. No period-over-period financial trends are available from these filings, but the insider patterns and capital allocation decisions provide actionable intelligence. The overall theme is caution in high-growth tech (CoreWeave) versus confidence in established AI platforms (Palantir), with Apple's insider sale adding a note of executive profit-taking.

1 high priority 6 medium 7 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 01, 2026

The 47 filings reveal a significant wave of activist and institutional repositioning, with several high-conviction moves and notable exits. Key themes include a broad de-escalation of activist intent by SIT Investment Associates across seven closed-end funds, transitioning from 13D to 13G filings, signaling a return to passive investment. Conversely, new activist stakes were established in Canterbury Park (9.35%) and Sono Group (21.5%), while Nokia's strategic investment in Inseego (14.2%) and Advent's continued engagement with Definitive Healthcare highlight corporate and PE-driven catalysts. Insider activity was mixed, with JinkoSolar's chairman reducing his stake and Tokyo Lifestyle's CEO increasing his via a debt-to-equity swap. Capital allocation actions include Mudrick's acquisition of Vroom's convertible notes and AMG's purchase of additional fund units. The most material event is American Express's exit from Global Business Travel Group following the merger close, while the most concentrated ownership is Mudrick's 76.1% stake in Vroom. Overall, the period is characterized by strategic repositioning, with a few high-impact catalysts and a broad trend towards passive investment in the closed-end fund space.

17 high priority 30 medium 47 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 01, 2026

This batch of 20 filings from the S&P 500 Financials sector is dominated by routine director stock awards and insider transactions, with no major earnings or strategic announcements. The most notable pattern is a cluster of deferred stock unit grants to 10 directors at American International Group (AIG), indicating standard compensation practices. A small but potentially significant insider sale by a 10% owner at AFLAC under a 10b5-1 plan warrants monitoring for future selling patterns. Goldman Sachs introduced a novel shareholder voting initiative (GS VIP) that could enhance retail engagement. The overall sentiment across filings is neutral, with low materiality, reflecting a period of normal corporate governance activity rather than fundamental business shifts. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in this batch, limiting the depth of trend analysis.

19 high priority 1 medium 20 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 01, 2026

The 11 filings for the S&P 500 Energy sector reveal a period of low operational volatility but high strategic activity. The most significant development is Baker Hughes' completed acquisition of Chart Industries, a transformative deal that positions the combined entity for growth in the LNG and industrial gas value chains. The remaining filings are dominated by routine director stock awards at APA Corp and a minor insider purchase at Texas Pacific Land Corp, indicating a lack of major operational or financial surprises from these companies. The period-over-period comparisons, forward-looking guidance, and other enriched data fields were largely absent from these specific filings, limiting the ability to identify broad sector trends. The primary actionable intelligence centers on the Baker Hughes acquisition's integration and the steady, albeit small, insider confidence signals from Texas Pacific Land. The sector appears to be in a consolidation phase, with capital allocation focused on strategic M&A rather than aggressive buybacks or dividend changes.

10 high priority 1 medium 11 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 01, 2026

The latest batch of 18 filings for S&P 500 Consumer Staples reveals a sector bifurcating between aggressive M&A-driven growth and steady, albeit modest, organic performance. McCormick & Co. stands out as the most transformative story, with its Q3 results showing a 17.4% net sales surge from the Mexico acquisition, but masking a tepid 1.9% organic growth and a sharp 57.1% GAAP EPS decline due to $153.9M in special charges. The company's pending Unilever Foods combination (expected close mid-2027) signals a major industry consolidation. Meanwhile, a wave of routine director stock awards at General Mills and Church & Dwight, alongside minor phantom stock grants, indicates normal compensation cycles with no insider conviction signals. The most critical development is the unexpected departure of Kimberly-Clark's President and COO Russell Torres, creating a leadership vacuum at a key operational level. Portfolio-level trends show a clear divergence: companies pursuing large-scale acquisitions are experiencing margin disruption and elevated debt, while those with organic focus maintain stability. The sector is entering a period of heightened M&A risk and execution scrutiny.

17 high priority 1 medium 18 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 01, 2026

The 16 filings in this digest are exclusively Form 4 insider ownership disclosures from five S&P 500 Industrials companies: Caterpillar, Lockheed Martin, Union Pacific, and Northrop Grumman. All transactions are director awards of phantom stock or common stock, reflecting routine compensation rather than open-market buying or selling. The absence of open-market insider purchases or sales across all filings suggests a neutral insider sentiment, with no executives or directors expressing conviction through personal capital. The most notable activity is at Union Pacific, where 10 directors received phantom stock awards totaling approximately $765K, with the largest single award to Michael R. McCarthy ($229K). Northrop Grumman directors received common stock awards, while Caterpillar and Lockheed Martin directors received smaller phantom stock awards. No forward-looking guidance, capital allocation changes, or operational metrics were disclosed in these filings. The sector theme is consistent: directors are being compensated in equity, aligning their interests with shareholders, but no actionable trading signals emerge from this data.

14 high priority 2 medium 16 total filings
· daily

US Material Events SEC 8-K Filings — October 01, 2026

The 50 filings from October 1, 2026, reveal a market sharply bifurcated between aggressive capital deployment and acute financial distress. A wave of transformative M&A and strategic investments is concentrated in the industrial and technology sectors, with Inseego, Liquidity Services, and CenterPoint Energy executing deals that will fundamentally reshape their competitive landscapes. Concurrently, a cluster of micro-cap and distressed companies, including Americas Carmart, Transcode Therapeutics, and Sadot Group, are navigating liquidity crises, going-concern warnings, and complex, contingent financing structures. The period-over-period data, while limited in this filing set, points to a clear trend of companies using equity and debt capital markets to fund growth (Pyxis, Sagimet, Runway Growth) while others are forced into dilutive or risky financing to survive. Insider activity is sparse but notable for its absence in several distressed situations, and forward-looking statements highlight a calendar packed with Phase 3 trial catalysts, merger completion dates, and critical waiver deadlines that will define the next quarter's winners and losers.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 01, 2026

**Insider Trading Pulse – October 1, 2026**: The digest captures 50 filings, dominated by routine director compensation (phantom stock, deferred units) and a few high-conviction open-market transactions. Key signals include a $5M insider purchase by Hyperscale Data's Executive Chairman at $0.50/share, a $560K CFO buy at Murphy USA, and a $2.13M CEO sale at an undisclosed company. Notable patterns include heavy insider selling by a CCO/GC (Wang Yanjun, ~$190K across 4 transactions) and multiple large dispositions to issuer (likely tax-related or buyback tenders). Sector-wise, no single theme dominates, but there is a mix of opportunistic buying in small/mid-caps and routine compensation in large caps. No guidance changes were flagged, but the absence of negative revisions suggests stability. The overall sentiment is neutral-to-cautiously-bullish, with selective high-conviction buys outweighing routine sells in dollar terms.

49 high priority 1 medium 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 01, 2026

This digest covers six US SEC filings from October 1, 2026, all within the corporate distress and bankruptcy stream. The dominant theme is a wave of Nasdaq and NYSE delisting actions, with three companies (Lantern Pharma, Gaxos.ai, Getty Images) receiving non-compliance or delisting notices due to market value, bid price, or abnormally low selling price failures. Getty Images has already been suspended and moved to the OTC market, while Lantern Pharma and Gaxos.ai have 180-day cure periods. A fourth company, SKYX Platforms, fell out of compliance due to a board member's death, triggering governance rule violations. NSTS Bancorp completed a cash merger and was voluntarily delisted, representing a clean exit. Nextdoor voluntarily transferred its listing from NYSE to Nasdaq, a non-distressed move. Period-over-period data was limited in these filings, but the concentration of delisting events signals heightened distress in small-cap and micro-cap equities, particularly in the AI and biotech sectors. Insider activity was absent across all filings, and no forward-looking guidance or capital allocation changes were disclosed, limiting trend analysis but amplifying the urgency of the compliance deadlines.

6 high priority 6 total filings
· daily

Global High-Priority Regulatory Events — October 01, 2026

This digest covers 50 high-priority market events from US SEC filings, dominated by a wave of delistings (10+ companies), insolvencies, and M&A completions. The most critical theme is the acceleration of small-cap and SPAC delistings, with 7 companies formally removed from Nasdaq/NYSE in a single week, signaling a severe liquidity and compliance crisis for micro-cap equities. M&A activity is bifurcated: large-scale strategic deals (CenterPoint's $2.62B divestiture, Gentherm/Modine Reverse Morris Trust) are closing successfully, while several SPAC mergers (Ripple/Evernorth, REEcycle) remain contingent on shareholder approvals. A notable cluster of insider-driven defaults and insolvencies in Indian markets (Siti Networks, SecureKloud) highlights ongoing stress in that jurisdiction. The aggregate period-over-period data reveals a clear pattern of asset sales being used to shore up balance sheets (Ashford Hospitality, CenterPoint) while companies like Getty Images and 5E Advanced Materials face existential liquidity threats. The key takeaway for investors is to avoid catching a falling knife in delisting micro-caps and to focus on the high-conviction, value-creating M&A where insiders have skin in the game.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 01, 2026

Today's US market digest reveals a bifurcated landscape: energy and biotech sectors show strong momentum with high-impact catalysts, while financial distress signals emerge in several small caps. Magnolia Oil & Gas's post-acquisition production surge and TotalEnergies' multi-project expansion highlight energy sector growth, while Monte Rosa's Phase 1 data and PolyPid's regulatory progress underscore biotech upside. Conversely, Americas Carmart faces potential restructuring, Transcode Therapeutics triggered a convertible note prepayment, and Pyxis Oncology's funding runway is contingent on warrant exercise. Insider activity is mostly routine (director awards), but notable buys in ASP Isotopes and MFS Municipal Income Trust contrast with sales in Adlai Nortye. Capital allocation trends show a mix of ATM offerings (Chesapeake Utilities), buybacks (Magnolia), and M&A (NSTS Bancorp merger completion). Key upcoming catalysts include PolyPid's PDUFA date (Nov 28), Magnolia's Q3 earnings, and multiple Phase 2 trial initiations in H1 2027.

38 high priority 12 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 01, 2026

The 19 filings in the S&P 500 Consumer Discretionary stream for October 1, 2026, reveal a sector bifurcated between operational resilience and cautious insider sentiment. NIKE's Q1 FY27 results are the standout, showing a mixed picture of revenue decline (-4% reported) and gross margin expansion (+60 bps), alongside a major restructuring program (Pace) targeting $2.5B in savings, which signals a strategic pivot but near-term uncertainty. The bulk of filings are routine director stock awards (Lowe's, Hilton, Marriott) and a small insider sale at Yum! Brands, indicating no broad-based insider buying or selling conviction. A notable pattern is the prevalence of director compensation via phantom stock or deferred stock at Lowe's and Marriott, suggesting a focus on long-term alignment. The only actionable negative signal is the KFC Division CEO's sale at Yum! Brands, which, while small, is executed under a 10b5-1 plan and warrants monitoring. Overall, the sector appears stable but lacks strong bullish catalysts from insider activity, with NIKE's restructuring being the key event to watch for execution risk and potential turnaround.

17 high priority 2 medium 19 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 01, 2026

The five filings for the USA S&P 500 Healthcare stream are dominated by routine insider equity awards and a procedural corporate action, lacking material financial performance data or forward-looking guidance. All insider transactions are non-cash, non-dilutive phantom stock awards to directors and executives at Merck and Pfizer, signaling standard compensation practices rather than conviction buying or selling. The Medtronic filing is a Rule 425 communication regarding a planned exchange offer to separate its MiniMed business, a significant strategic move that could unlock shareholder value but remains procedural at this stage. No period-over-period financial trends, capital allocation changes, or guidance updates were present in any filing, limiting the depth of quantitative synthesis. The overall sentiment across all filings is neutral, with low materiality scores (3-5/10), indicating no immediate actionable signals for investors. The digest focuses on the strategic implications of Medtronic's separation and the benign nature of the insider awards, while flagging the absence of performance data as a key limitation.

5 high priority 5 total filings
· daily

US Earnings Financial Results SEC Filings — October 01, 2026

The six filings reveal a bifurcated market landscape: two SPACs (Bowen Acquisition Corp and Karman Line Acquisition Corp) show minimal operational substance with declining cash reserves and shareholder deficits, while established operating companies TD SYNNEX and McCormick report strong revenue growth but face margin compression and elevated leverage from M&A. NaturalShrimp is in liquidation with net liabilities of $8.88M, highlighting extreme distress. Key period-over-period trends include TD SYNNEX's 37.7% YoY revenue surge but 60 bps gross margin decline, and McCormick's 127% net income increase over nine months driven by a one-time $866.8M gain, masking a 52.8% drop in Q3 net income. Insider trading activity is absent across all filings, limiting conviction signals. Forward-looking data is sparse, but scheduled events like earnings calls for TD SYNNEX and McCormick present near-term catalysts. Capital allocation patterns show TD SYNNEX investing heavily in working capital (operating cash flow of -$2.08B) while McCormick levered up for a $1.75B acquisition, increasing short-term borrowings 251%.

6 high priority 6 total filings